Growth Metrics

Beta Bionics (BBNX) Change in Accured Expenses (2024 - 2026)

Beta Bionics' Change in Accured Expenses history spans 3 years, with the latest figure at -$5.2 million for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses rose 1.06% to -$5.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $7.5 million, a 316.48% increase, with the full-year FY2025 number at $7.4 million, up 8.57% from a year prior.
  • Change in Accured Expenses hit -$5.2 million in Q1 2026 for Beta Bionics, down from $5.9 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for BBNX hit a ceiling of $5.9 million in Q4 2025 and a floor of -$5.3 million in Q1 2025.
  • Historically, Change in Accured Expenses has averaged $1.0 million across 3 years, with a median of $2.3 million in 2024.
  • The widest YoY moves for Change in Accured Expenses: up 242.92% in 2025, down 2182.68% in 2025.
  • Tracing BBNX's Change in Accured Expenses over 3 years: stood at $3.6 million in 2024, then surged by 64.16% to $5.9 million in 2025, then plummeted by 189.04% to -$5.2 million in 2026.
  • Business Quant data shows Change in Accured Expenses for BBNX at -$5.2 million in Q1 2026, $5.9 million in Q4 2025, and $4.1 million in Q3 2025.